#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA665988	B	In silico binding affinity to human corticosteriod binding globulin		31		single protein format	Scientific Literature
2.	ALA665992	B	In silico binding affinity to corticosteroid binding globulin (CBG)		31		single protein format	Scientific Literature
3.	ALA665993	B	Compound was evaluated for its binding affinity towards the human corticosteroid binding globulin		10		single protein format	Scientific Literature
4.	ALA663464	B	In silico steroid binding affinity to transport protein corticosteroid binding globulin		31		single protein format	Scientific Literature
5.	ALA681326	B	Inhibition of human Farnesyltransferase at 100 uM	Homo sapiens	3		protein complex format	Scientific Literature
6.	ALA1040691	F	NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614		organism-based format	Novartis Malaria Screening
7.	ALA1040692	F	NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614		organism-based format	Novartis Malaria Screening
8.	ALA1040693	T	NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)	Homo sapiens	5,614		cell-based format	Novartis Malaria Screening
9.	ALA1040694	F	NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.		5,614		assay format	Novartis Malaria Screening
10.	ALA2354254	F	PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory)		153,867		assay format	PubChem BioAssays
11.	ALA3561990	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel. (Class of assay: confirmatory)		2,189		assay format	PubChem BioAssays
12.	ALA3562064	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel. (Class of assay: confirmatory)		1,996		assay format	PubChem BioAssays
13.	ALA3562110	F	PubChem BioAssay. A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase. (Class of assay: confirmatory)		1,981		cell-based format	PubChem BioAssays
14.	ALA3562119	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel. (Class of assay: confirmatory)		2,170		assay format	PubChem BioAssays
15.	ALA3562136	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel. (Class of assay: confirmatory)		1,968		assay format	PubChem BioAssays
16.	ALA3562146	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel. (Class of assay: confirmatory)		1,812		assay format	PubChem BioAssays
17.	ALA3562152	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel. (Class of assay: confirmatory)		1,822		assay format	PubChem BioAssays
18.	ALA4303805	F	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging	Homo sapiens	5,612		organism-based format	SARS-CoV-2 Screening Data 2020-21
19.	ALA4495582	F	SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate	Severe acute respiratory syndrome coronavirus 2	7,212		assay format	SARS-CoV-2 Screening Data 2020-21
20.	ALA4513082	F	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging	Chlorocebus sabaeus	7,212		organism-based format	SARS-CoV-2 Screening Data 2020-21